Skip to main content
. 2011 Dec;32(11):2093–2097. doi: 10.3174/ajnr.A2691

Table 5:

Number of patients per treatment arm necessary to perform parallel grouped placebo-controlled clinical trialsa

% Decrease in Mean Number of Enhancing Lesions No.
50 129
60 80
70 47
80 28
90 12
a

To detect a percentage decrease in the mean number of enhancing lesions ranging from 50% to 90%, for a power of 80%.